What type of study is this?

This is a Literature Review study.

ScreeningLessons from Prediction and Prevention of Type 1 Diabetes

View Full Paper

Ask AI

Bookmark

Authors

Research identifies autoantibodies for predicting type 1 diabetes, suggesting effective FDA-approved therapy to delay onset.

Individuals can be identified for type 1 diabetes using tests for autoantibodies, allowing early intervention and monitoring.
Robust data show that nearly all individuals with 2 or more autoantibodies will progress to clinical type 1 diabetes.
Multicenter research over decades led to the development of therapies that delay disease progression and improve outcomes.
While translating these findings into clinical practice poses challenges, an approved therapy indicates a promising future for type 1 diabetes prevention.

Speake et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark